Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Leukemia, Myeloid, Acute 1

Interventions

Methotrexate 9Cyclophosphamide 9fludarabine phosphate 7Vincristine 7Rituximab 7Tacrolimus 6Cytarabine 6nelarabine 5Whole-Body Irradiation 5Peripheral Blood Stem Cell Transplantation 5Mycophenolic Acid 5Filgrastim 5Dexamethasone 5Antilymphocyte Serum 5pegaspargase 4merphos 4Prednisone 4Granulocyte Colony-Stimulating Factor 4Etoposide 4Calcium Dobesilate 4tanespimycin 3dexamethasone acetate 3dexamethasone 21-phosphate 3Radiotherapy 3Lenalidomide 3Doxorubicin 3Busulfan 3Bortezomib 3prednylidene 2deltacortene 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Precursor T-Cell Lymphoblastic Leukemia-Lymphoma × 4-fluorobenzoyl-TN-14003 × Clear all
NCT02763384 2023-10-31

BL-8040 and Nelarabine for Relapsed or Refractory T-Acute Lymphoblastic Leukemia/ Lymphoblastic Lymphoma

Washington University School of Medicine

Phase 2 Terminated
12 enrolled 14 charts
LymphoidOther hematologic neoplasm

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡